|
4ZP4
Crystal Structure of the Heterodimeric HIF-2a:ARNT Complex
Deposited 2015-05-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
82–464(383 aa)
Fragment:UNP residues 82-464
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;289 K;2% Tacsimate, pH 7.0, 6% PEG3350
|
Resolution 2.35 Å
R-free 0.232
|
|
4ZP4
Crystal Structure of the Heterodimeric HIF-2a:ARNT Complex
Deposited 2015-05-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
82–464(383 aa)
Fragment:UNP residues 82-464
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;289 K;2% Tacsimate, pH 7.0, 6% PEG3350
|
Resolution 2.35 Å
R-free 0.232
|
|
4ZPH
Crystal Structure of the Heterodimeric HIF-2a:ARNT Complex with Proflavine
Deposited 2015-05-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
82–464(383 aa)
Fragment:UNP residues 82-464
|
Not recorded
|
PRL PROFLAVIN × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;289 K;2% Tacsimate, pH 7.0, 6% PEG3350
|
Resolution 2.80 Å
R-free 0.221
|
|
4ZPH
Crystal Structure of the Heterodimeric HIF-2a:ARNT Complex with Proflavine
Deposited 2015-05-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
82–464(383 aa)
Fragment:UNP residues 82-464
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;289 K;2% Tacsimate, pH 7.0, 6% PEG3350
|
Resolution 2.80 Å
R-free 0.221
|
|
4ZPK
Crystal Structure of the Heterodimeric HIF-2a:ARNT Complex with HRE DNA
Deposited 2015-05-08
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 2
PDB declaration: tetrameric
|
Chain A
82–464(383 aa)
Fragment:UNP residues 82-464
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;289 K;4% Tacsimate, pH 6.0, 10% PEG3350
|
Resolution 3.60 Å
R-free 0.321
|
|
4ZPR
Crystal Structure of the Heterodimeric HIF-1a:ARNT Complex with HRE DNA
Deposited 2015-05-08
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 2
PDB declaration: tetrameric
|
Chain A
82–464(383 aa)
Fragment:UNP residues 82-464
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;289 K;100 mM MES, pH 6.0, 100 mM calcium acetate, 15% PEG400
|
Resolution 3.90 Å
R-free 0.341
|
|
4ZQD
Crystal Structure of the Heterodimeric HIF-2a:ARNT Complex with the Benzoxadiazole Antagonist 0X3
Deposited 2015-05-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
82–464(383 aa)
Fragment:UNP residues 82-464
|
Not recorded
|
0X3 N-(3-chloro-5-fluorophenyl)-4-nitro-2,1,3-benzoxadiazol-5-amine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;289 K;2% Tacsimate, pH 7.0, 6% PEG3350
|
Resolution 2.87 Å
R-free 0.254
|
|
4ZQD
Crystal Structure of the Heterodimeric HIF-2a:ARNT Complex with the Benzoxadiazole Antagonist 0X3
Deposited 2015-05-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
82–464(383 aa)
Fragment:UNP residues 82-464
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;289 K;2% Tacsimate, pH 7.0, 6% PEG3350
|
Resolution 2.87 Å
R-free 0.254
|
|
5SY5
Crystal Structure of the Heterodimeric NPAS1-ARNT Complex
Deposited 2016-08-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
82–464(383 aa)
Fragment:unp residues 82-464
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;289 K;2% Tacsimate pH 7.0, 3% PEG3350
|
Resolution 3.20 Å
R-free 0.247
|
|
5SY5
Crystal Structure of the Heterodimeric NPAS1-ARNT Complex
Deposited 2016-08-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
82–464(383 aa)
Fragment:unp residues 82-464
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;289 K;2% Tacsimate pH 7.0, 3% PEG3350
|
Resolution 3.20 Å
R-free 0.247
|
|
5SY5
Crystal Structure of the Heterodimeric NPAS1-ARNT Complex
Deposited 2016-08-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain E
82–464(383 aa)
Fragment:unp residues 82-464
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;289 K;2% Tacsimate pH 7.0, 3% PEG3350
|
Resolution 3.20 Å
R-free 0.247
|
|
5SY5
Crystal Structure of the Heterodimeric NPAS1-ARNT Complex
Deposited 2016-08-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
82–464(383 aa)
Fragment:unp residues 82-464
Chain C
82–464(383 aa)
Fragment:unp residues 82-464
Chain E
82–464(383 aa)
Fragment:unp residues 82-464
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;289 K;2% Tacsimate pH 7.0, 3% PEG3350
|
Resolution 3.20 Å
R-free 0.247
|
|
5SY7
Crystal Structure of the Heterodimeric NPAS3-ARNT Complex with HRE DNA
Deposited 2016-08-10
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 2
PDB declaration: tetrameric
|
Chain A
82–464(383 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;289 K;100 mM NH4F, 9% PEG 3350
|
Resolution 4.20 Å
R-free 0.361
|
|
6E3S
Crystal Structure of the Heterodimeric HIF-2 Complex with Antagonist PT2385
Deposited 2018-07-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
82–464(383 aa)
|
Not recorded
|
79A 3-{[(1S)-2,2-difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl]oxy}-5-fluorobenzonitrile × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;289 K;2% TACSIMATE, PH 7.0, 6% PEG3350
|
Resolution 3.00 Å
R-free 0.249
|
|
6E3T
Crystal Structure of the Heterodimeric HIF-2 Complex with Antagonist T1001
Deposited 2018-07-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
82–464(383 aa)
|
Not recorded
|
HO7 (6S)-6-(4-bromophenyl)-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;289 K;2% TACSIMATE, PH 7.0, 6% PEG3350
|
Resolution 3.00 Å
R-free 0.306
|
|
6E3U
Crystal Structure of the Heterodimeric HIF-2 Complex with Agonist M1001
Deposited 2018-07-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
82–464(383 aa)
|
Not recorded
|
HNJ 3-{[2-(pyrrolidin-1-yl)phenyl]amino}-1H-1lambda~6~,2-benzothiazole-1,1-dione × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;2% TACSIMATE, PH 7.0, 6% PEG3350
|
Resolution 2.85 Å
R-free 0.258
|
|
7V7L
Crystal Structure of the Heterodimeric HIF-3a:ARNT Complex
Deposited 2021-08-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
82–464(383 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;289 K;Sodium citrate tribasic dihydrate, 2-Propanol, PEG 4000
|
Resolution 2.30 Å
R-free 0.245
|
|
7V7W
Crystal Structure of the Heterodimeric HIF-3a:ARNT Complex with oleoylethanolamide (OEA)
Deposited 2021-08-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
82–464(383 aa)
Fragment:Hydrocarbon receptor nuclear translocator ARNT
|
Not recorded
|
5YM (Z)-N-(2-hydroxyethyl)octadec-9-enamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;289 K;Sodium citrate tribasic dihydrate, 2-Propanol, PEG 4000
|
Resolution 2.51 Å
R-free 0.260
|
|
7VNI
AHR-ARNT PAS-B heterodimer
Deposited 2021-10-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
358–466(109 aa)
|
Not recorded
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M sodium arsenate (pH 6.5), 0.2 M MgCl2, 2 M (NH4)2SO4
|
Resolution 2.00 Å
R-free 0.219
|
|
7VNI
AHR-ARNT PAS-B heterodimer
Deposited 2021-10-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
358–466(109 aa)
|
Not recorded
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M sodium arsenate (pH 6.5), 0.2 M MgCl2, 2 M (NH4)2SO4
|
Resolution 2.00 Å
R-free 0.219
|
|
7W80
Crystal Structure of the Heterodimeric HIF-2 in Complex with Antagonist Belzutifan
Deposited 2021-12-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
82–464(383 aa)
|
Not recorded
|
72Q 3-{[(1S,2S,3R)-2,3-difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl]oxy}-5-fluorobenzonitrile × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;289 K;Tacsimate, PEG3350
|
Resolution 2.75 Å
R-free 0.274
|
|
7XHV
Crystal Structure of the NPAS4-ARNT heterodimer in complex with DNA
Deposited 2022-04-10
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 2
PDB declaration: tetrameric
|
Chain A
82–360(279 aa)
Fragment:ARNT
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 8;289 K;ammonium tartrate dibasic, PEG3350
|
Resolution 4.00 Å
R-free 0.331
|
|
7XI4
Crystal Structure of the NPAS4-ARNT heterodimer in complex with DNA
Deposited 2022-04-12
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 2
PDB declaration: tetrameric
|
Chain A
82–464(383 aa)
Fragment:ARNT
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 8;289 K;ammonium tartrate dibasic, PEG3350
|
Resolution 4.71 Å
R-free 0.351
|
|
9LJX
Crystal Structure of the Heterodimeric HIF-2 Complex with Agonist SD-26
Deposited 2025-01-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
82–464(383 aa)
|
Not recorded
|
A1EKB 4-fluoranyl-~{N}-(3-fluoranyl-2-pyrrolidin-1-yl-phenyl)-1,1-bis(oxidanylidene)-1,2-benzothiazol-3-amine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;PEG 3350, Succinic Acid pH 7.0
|
Resolution 2.80 Å
R-free 0.268
|
|
9LJY
Crystal Structure of the Heterodimeric HIF-2 Complex with Agonist SD-14
Deposited 2025-01-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
82–464(383 aa)
|
Not recorded
|
A1EJ9 4-chloranyl-1,1-bis(oxidanylidene)-~{N}-(2-pyrrolidin-1-ylphenyl)-1,2-benzothiazol-3-amine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;PEG 3350, Succinic Acid pH 7.0
|
Resolution 3.20 Å
R-free 0.248
|
|
9LOH
Crystal Structure of the Heterodimeric HIF-2 Complex with Agonist SD-10
Deposited 2025-01-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
82–464(383 aa)
|
Not recorded
|
A1EJ8 4-fluoranyl-1,1-bis(oxidanylidene)-~{N}-(2-pyrrolidin-1-ylphenyl)-1,2-benzothiazol-3-amine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;PEG 3350, Succinic Acid pH 7.0
|
Resolution 3.02 Å
R-free 0.262
|
|
9LOI
Crystal Structure of the Heterodimeric HIF-2 Complex with Agonist SD-16
Deposited 2025-01-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
82–464(383 aa)
|
Not recorded
|
A1EKA 6-chloranyl-1,1-bis(oxidanylidene)-~{N}-(2-pyrrolidin-1-ylphenyl)-1,2-benzothiazol-3-amine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;PEG 3350, Succinic Acid pH 7.0
|
Resolution 2.78 Å
R-free 0.275
|